Related Experiment Video
Updated: Jul 16, 2026

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
Single-Cell Pan-Cancer Atlas Reveals GPR171 as a Candidate Marker of CD8+ T-Cell Dysfunction
Xinyu Pan1, Ao Zhang1, Yuanyan Xiong1
1Key Laboratory of Gene Engineering of the Ministry of Education, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.
Abstract:
CD8+ T-cell exhaustion is a key mechanism of tumor immune evasion and a major limitation of current cancer immunotherapy. However, the molecular factors sustaining dysfunctional CD8+ T-cell states across cancers are not fully understood. Here, we identify GPR171 as a common feature of exhausted CD8+ T cells across multiple solid tumors based on integrated pan-cancer single-cell transcriptomic analyses. GPR171 is enriched in exhausted CD8+ T cells and is closely associated with immunosuppressive and exhaustion-related gene programs. It also shows a strong association with key immune regulatory genes such as CTLA4 and NR4A2. Functional analyses suggest that reduced GPR171 activity is associated with decreased expression of exhaustion-related genes and a shift toward cytotoxic and immune-activating programs. In parallel, a CREM-centered regulatory network emerges in exhausted CD8+ T cells and may act in concert with GPR171-associated programs to reinforce dysfunctional states. Overall, our results identify GPR171 as a candidate marker of CD8+ T-cell dysfunction across cancers and provide a systematic pan-cancer single-cell characterization of its association with immunosuppressive T-cell states, supporting its potential as a therapeutic target for restoring antitumor immunity.
Insights
Researchers identified GPR171 as a key marker of exhausted CD8+ T cells in various cancers. Reducing GPR171 activity may help restore antitumor immunity, offering a potential therapeutic target.
Area of Science:
- Immunology
- Oncology
- Genomics
Background:
- CD8+ T-cell exhaustion hinders cancer immunotherapy by promoting tumor immune evasion.
- The molecular drivers of T-cell dysfunction across diverse cancers remain incompletely understood.
Purpose of the Study:
- To identify molecular factors associated with exhausted CD8+ T cells in pan-cancer analysis.
- To investigate the role of GPR171 in CD8+ T-cell dysfunction and its therapeutic potential.
Main Methods:
- Integrated pan-cancer single-cell transcriptomic analysis.
- Association analysis of GPR171 with gene expression profiles and immune regulatory genes.
- Functional analysis of GPR171 activity in T cells.
Main Results:
- GPR171 is commonly enriched in exhausted CD8+ T cells across multiple solid tumors.
- GPR171 expression correlates with immunosuppressive and exhaustion-related gene programs, including CTLA4 and NR4A2.
- Reduced GPR171 activity is linked to decreased exhaustion markers and enhanced cytotoxic/immune-activating programs, alongside a CREM-centered network.
Conclusions:
- GPR171 serves as a potential pan-cancer marker for CD8+ T-cell dysfunction.
- GPR171's association with immunosuppressive states highlights its potential as a therapeutic target to enhance antitumor immunity.

